COMPARISON OF EFFICIENCY AND SAFETY Of CO-DIROTON, ENALAPRIL AND HYDROCHLOROTHIAZIDE IN PSORIATIC PATIENTS WITH ARTERIAL HYPERTENSION AND OVERWEIGHT
- Авторлар: Shevchenko O.P.1, Dvoryankova E.V.1, Shevchenko A.O.1, Shilova Y.V.1, Shevchenko AO1, Dvoryankova Y.V1, Shevchenko OP1, Shilova Y.V1
-
Мекемелер:
- Шығарылым: № 20 (2010)
- Беттер: 76-82
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278737
- ID: 278737
Дәйексөз келтіру
Толық мәтін
Аннотация
Негізгі сөздер
Авторлар туралы
Oleg Shevchenko
Evgeniya Dvoryankova
Aleksey Shevchenko
Yuliya Shilova
A Shevchenko
Ye Dvoryankova
O Shevchenko
Yu Shilova
Әдебиет тізімі
- National Psoriasis Foundation. Psoriasis statistics. Доступно в сети Интернет по адресу: http://www.psoriasis.org Последнее обращение: 06.12.2010.
- Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis. Arch Dermatol 2007;143:1493-99.
- Nakagami T, Qiao Q, Tuomilehto J, et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 2006;13(4):555-61.
- Pearce DJ, Morrison AE, Higgins KB, et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 2005;16(5-6):319-23.
- Gelfand JM, Feldman SR, Stern RS, et al. Determinant of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004;51:704-08.
- Qureshi АA, Choi HK, Setty AR, et al. Psoriasis and the Risk of Diabetes and Hypertension: A Prospective Study of US Female Nurses. Arch Dermatol 2009;145(4):379-82.
- Nakagami T, Qiao Q, Tuomilehto J, et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 2006;13(4):555-61.
- Pearce DJ, Morrison AE, Higgins KB, et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatol Treat 2005;16(5-6):319-23.
- Kim GK, Del Rosso JQ. Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated? Understanding Pathophysiology and Clinical Relevance. J Clin Aesthet Dermatol 2010;3(1):32-38.
- Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
- Адаскевич В.П. Диагностические индексы в дерматологии. Медицинская книга. М., 2004. С.107-108.
- Kimball AB, Gladman D, Gelfand JM, et al. National psoriasis foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008;58:1031-42.
- Dratelin CR, Martinez-Abundis E, Balcazar-Munoz BR, et al. Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. J Am Acad Dermatol 2003;48:882-85.
- Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, et al. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001;303:33-39.
- Дворянкова Е.В., Шевченко А.О., Шевченко О.П., Новосельцев М.В., Орлова О.В., Гинзбург Л.М. Эффективность и безопасность симвастатина у больных распространенным псориазом // Дальневосточный вестник дерматовенерологии, косметологии и пластической хирургии. 2010. №1 (7). С. 22-26.
- Gelfand JM, Feldman SR, Stern RS, et al. Determinant of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004;51:704-08.
- Ravipati G, Aronow WS, Ahn C, et al. Incidence of new stroke or new myocardial infarction or death at 39-month follow-up inpatients with diabetes mellitus, hypertension or both with and without microalbuminuria. Cardiology 2008;109(1):62-65.
- Gibson SH, Perry HO. Diabetes and psoriasis. AMA Arch Derm 1956;74(5):487-88.
- Cohen AD, Sherf M, Vidavsky L, et al. Association between psoriasis and the metabolic syndrome: a cross-sectional study. Dermatology 2008;216(2):152-55.
- Ravipati G, Aronow WS, Ahn C, et al. Incidence of new stroke or new myocardial infarction or death at 39-month follow-up in patients with diabetes mellitus, hypertension or both with and without microalbuminuria. Cardiology 2008;109(1):62-65.
- Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55(5):829-35.
- Qureshi АA, Choi HK, Setty AR, et al. Psoriasis and the Risk of Diabetes and Hypertension: A Prospective Study of US Female Nurses. Arch Dermatol 2009;145(4):379-82.
- Al-Awadhi AM, Hasan EA, Sharma PN, et al. Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis. Rheumatol Int 2007;27(12):1119-23.
- Huskic J, Alendar F. Tissue angiotensin-converting enzyme in patients with various clinical forms of psoriasis. Bosn J Basic Med Sci 2007;7(2):103-06.
- Rodgers K, Xiong S, Felix J, et al. Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen 2001;9:238-47.
- Moscarelli L, Zanazzi M, Mancini G, et al. Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients. Clin Nephrol 2010;73(6):439-45.
- Шевченко А.О., Шевченко О.П. Фиксированная низкодозовая комбинация лизиноприла и гидрохлортиазида в профилактике сердечно-сосудистых событий у больных артериальной гипертонией // Рациональная фармакотерапия в кардиологии. 2010. № 6(5). C. 697-702.
- Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med 1996;156(17):1969-78.
- Patel BV, Remigio-Baker RA, Thiebaud P, et al. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy. BMC Fam Pract 2008;9:6.
- Motwani JG. Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension. JRAAS 2002;3:72-8
- Law MR, Wald NJ, Morris JK, et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326(7404):1427.